About the role
GRAIL is seeking a Staff Site Reliability / DevOps Engineer to lead the reliability, scalability, and security of our cloud-native platform. This role operates at the intersection of infrastructure engineering, platform strategy, and organizational leadership, supporting systems that power large-scale data processing and cutting-edge cancer detection technologies.
You will define and drive infrastructure standards across teams, represent reliability and performance in architecture decisions, and build systems that scale well beyond your direct ownership. This is a highly technical, high-impact role combining hands-on engineering with cross-functional influence and mentorship.
Onsite Expectations You will work on-site full-time at our office located in Menlo Park, California. Beginning in Fall 2026, you will work at our new headquarters in Sunnyvale, California.
Aplyr's read
GRAIL is at the forefront of healthcare innovation, leveraging genomic technology for early cancer detection, attracting talent in engineering, science, and market access.
What's promising
- •GRAIL's focus on early cancer detection addresses a critical need in healthcare.
- •The company is backed by significant investment, supporting research and development.
- •Recent hiring in diverse roles indicates growth and expansion in operations.
What to watch
- •The biotechnology sector is highly competitive, with rapid technological advancements.
- •Regulatory challenges in healthcare can impact timelines and product launches.
- •GRAIL's success heavily depends on the accuracy and reliability of its technology.
Why GRAIL
- •GRAIL uses cutting-edge genomic technology for non-invasive cancer detection.
- •The company has a strong focus on integrating data science with healthcare.
- •GRAIL's mission-driven approach attracts professionals passionate about impactful healthcare solutions.
Aplyr’s read is generated by AI from public sources. Was it useful?
About GRAIL
GRAIL is a healthcare company focused on early cancer detection through advanced genomic technology.